Experimental therapies do exist in public healthcare systems, the costs are generally borne by the universities with special financing for experimental treatments. Many universities in public systems are run directly by universities which simplifies the process.
A number of gene therapies are to expensive for any public health system, so are only available in the us.
Needles to say they're experimental and carry lots of weight in a effectiveness vs cost analysis.